{"database": "lobbying", "table": "lobbying_activities", "rows": [[1996301, "6c606795-50f4-4ab0-9395-23ec8e4365a4", "Q2", "BUCHANAN INGERSOLL & ROONEY PC", 55291, "TONIX PHARMACEUTICALS HOLDING CORP.", 2017, "second_quarter", "PHA", "Federal funding related to clinical trials for military PTSD; FY 2018 NDAA and Defense Appropriations", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2017-07-19T13:30:43.243000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1996301"], "units": {}, "query_ms": 58.02337499335408, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}